Pancreatic Cancer and Personalized Medicine: Can Genomics Facilitate Early Diagnosis or Improve Therapeutic Outcomes?
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
73-88
Author(s):
A. S. Strimpakos, C. Hoimes, K. N. Syrigos and M. W. Saif
Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
411-420
Author(s):
David Hirst and Tracy Robson
Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
555-566
Author(s):
Rudolf L. Then and Hans-Georg Sahl
Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
584-596
Author(s):
G. Candore, C. Caruso, E. Jirillo, T. Magrone and S. Vasto
Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
725-733
Author(s):
Cecilia Menna, Fabiola Olivieri, Alfonso Catalano and Antonio Procopio
Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes
Journal:
Current Enzyme Inhibition
Volume:
6
Page:
34-45
Author(s):
Armando Rojas, Deyarina Gonzalez, Hector Figueroa, Miguel A. Morales and Jacqueline Romero
Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
34-40
Author(s):
Xinhai Zhang, Rick F. Thorne, Thomas E. Wagner and Yanzhang Wei
Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
55-67
Author(s):
A. Russo, G. Bronte, F. Fulfaro, G. Cicero, V. Adamo, N. Gebbia and S. Rizzo
Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
68-79
Author(s):
A. Ruzzo, F. Graziano, E. Canestrari and M. Magnani
Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
117-126
Author(s):
M. Masuda, T. Wakasaki, M. Suzui, S. Toh, A. K. Joe and I. B. Weinstein